Healthcare company-building profile
UNC Eshelman Institute for Innovation
University of North Carolina at Chapel Hill (Eshelman School of Pharmacy)
Source-based profile
Program at a Glance
- Program type
- Venture studio
- Program category
- Venture studio
- Organization
- University of North Carolina at Chapel Hill (Eshelman School of Pharmacy)
- Organization type
- Not publicly documented
- Location
- Chapel Hill, North Carolina
- Company stage served
- Research or idea stage
- Cohort or participation model
- Rolling funding calls through the Therapeutics Accelerator and Venture Studio
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Not publicly documented
- Equity or fee model
- Not publicly documented
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
Public description
About the program
The Eshelman Institute for Innovation funds and builds healthcare therapeutics and digital health ventures out of UNC-Chapel Hill research. It operates a Therapeutics Accelerator that funds novel therapeutics after proof of concept and a Venture Studio that develops venture-backable digital health startups. Its portfolio spans pandemics and infectious disease, substance use disorders, cancer therapeutics and diagnostics, and mental health. Its READDI antiviral drug development initiative has raised close to $100 million.
What the program publicly emphasizes
Focus areas and features
- Category: Venture studio
- Program structure: Rolling funding calls through the Therapeutics Accelerator and Venture Studio
Publicly documented people and network
Program leadership and alumni
- Notable alumni named in public materials
- READDI; Kairos; TerraLink
Sources
External source links open in a new tab.